Clinical Trials Directory

High Dose Sequential Therapy and Autologous Stem Cell Rescue for Multiple Myeloma

To assess the role of autologous hematopoietic cell rescue in the treatment of multiple myeloma.

Stanford is not currently accepting new patients for this trial. You may want to check to see if other locations are recruiting.



  • procedure : high dose chemotherapy then autologous hematopoietic cell transplant

Phase: Phase 2


Ages Eligible For Study:

18 Years - 75 Years

Inclusion Criteria

- received cytoreduction prior to transplant - adequate organ function

External Links

Explore related trials

Contact information

Primary Contact:

BMT Referrals 6507230822

Stanford University School of Medicine 300 Pasteur Drive Stanford, CA 94305

Stanford Medicine Resources:

Footer Links: